Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Striatal dopamine D2-receptor blockade by typical and atypical neuroleptics.

× No keyword cloud information.

8 in total

1. Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine--a 123I IBZM single photon emission tomography (SPET) study.

Authors: L S Pilowsky; G F Busatto; M Taylor; D C Costa; T Sharma; T Sigmundsson; P J Ell; V Nohria; R W Kerwin
Journal: Psychopharmacology (Berl) Date: 1996-03 Impact factor: 4.530

2. D2-dopamine-receptor occupancy during treatment with haloperidol decanoate.

Authors: J Scherer; K Tatsch; M Albus; J Schwarz; T Mager; W H Oertel
Journal: Eur Arch Psychiatry Clin Neurosci Date: 1997 Impact factor: 5.270

3. Clozapine: an appraisal of its pharmacoeconomic benefits in the treatment of schizophrenia.

Authors: A Fitton; P Benfield
Journal: Pharmacoeconomics Date: 1993-08 Impact factor: 4.981

Review 4. Interventional brain SPECT--a review.

Authors: H J Biersack; E Klemm; C Menzel; K Reichmann; W J Shih; F Grünwald
Journal: Ann Nucl Med Date: 1996-08 Impact factor: 2.668

Review 5. Traditional receptor theory and its application to neuroreceptor measurements in functional imaging.

Authors: R W Kerwin; L S Pilowsky
Journal: Eur J Nucl Med Date: 1995-07

Review 6. D2-receptor imaging with [123I]IBZM and single photon emission tomography in psychiatry: a survey of current status.

Authors: R Schlösser; S Schlegel
Journal: J Neural Transm Gen Sect Date: 1995

Review 7. Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging.

Authors: O D Howes; A Egerton; V Allan; P McGuire; P Stokes; S Kapur
Journal: Curr Pharm Des Date: 2009 Impact factor: 3.116

Review 8. Glutamate and dopamine in schizophrenia: an update for the 21st century.

Authors: Oliver Howes; Rob McCutcheon; James Stone
Journal: J Psychopharmacol Date: 2015-01-13 Impact factor: 4.153

8 in total